Integrative analysis of adenosine-related RNA modifications defines molecular subtypes of bladder cancer and identifies CES1 as a driver of tumor progression and immunotherapy resistance. [PDF]
BMC CancerHuo X +5 more
europepmc +1 more source
Flumazenil reversal of remimazolam-induced sedation: a narrative review of safety, pharmacokinetics, and clinical considerations. [PDF]
Front Med (Lausanne)Zhou Y +7 more
europepmc +1 more source
Niraparib PBPK modeling to predict optimal dosage in patients with hepatic impairment. [PDF]
Front PharmacolPokladyuk A +4 more
europepmc +1 more source
Pharmacogenomics of direct oral anticoagulants: a systematic review and meta-analysis. [PDF]
Front Cardiovasc MedChai H, Huo J, Chen H.
europepmc +1 more source
Ester Prodrug NLRP3 Inflammasome Inhibitor NT-0796 is Brain Active due to Activation by Local Expression of Carboxylesterase-1. [PDF]
ACS Chem NeurosciDigby Z +8 more
europepmc +1 more source
Production of Novel Thermostable Esterases from <i>Thermus thermophilus</i> Strain ET-1 in <i>Escherichia coli</i> and <i>Thermus thermophilus</i> HB27 Using the Bifunctional Expression System pTGT-1 and Characterization of the Recombinant Enzymes. [PDF]
Int J Mol SciValenzuela B +6 more
europepmc +1 more source
Pharmacogenomic profiling of ABCB1 and CES1 in atrial fibrillation patients on dabigatran from a multiethnic Malaysian cohort. [PDF]
Sci RepTan SSN +10 more
europepmc +1 more source
Experimental and In Silico Approaches to Study Carboxylesterase Substrate Specificity. [PDF]
J XenobiotRibone SR, Quevedo MA.
europepmc +1 more source
Dose Recommendation of Remimazolam Tosilate for General Anesthesia in Children and Adolescents: Synergistic Combination of PopPK and PBPK Approaches. [PDF]
PharmaceuticsLiang QY +4 more
europepmc +1 more source
Network toxicology & molecular docking: endocrine-disrupting chemicals induce prostate cancer - a system study. [PDF]
Int J Clin Exp PatholZhou Y +5 more
europepmc +1 more source